Zobrazeno 81 - 90
of 258
pro vyhledávání: ''
Autor:
Harneetpal Kaur, Kirandeep Kaur, Atamjit Singh, Neena Bedi, Balbir Singh, Mansour S. Alturki, Mohammed F. Aldawsari, Atiah H. Almalki, Shafiul Haque, Hae-Jeung Lee, Dharmendra K. Yadav, Saroj Arora
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Nanoformulation-based combinational drug delivery systems are well known to overcome drug resistance in cancer management. Among them, nanoemulsions are well-known and thermodynamically stable drug delivery systems suitable for carrying hydrophobic d
Externí odkaz:
https://doaj.org/article/2e63a133fb274d47a419e2b81a40f9d4
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Breast cancer (BC) is one of the most common malignant tumor, the incidence of which has increased worldwide in recent years. Ginsenosides are the main active components of Panax ginseng C. A. Mey., in vitro and in vivo studies have confirmed that gi
Externí odkaz:
https://doaj.org/article/591e1ffe439c4b5bb1b56736cb4f8c7e
Autor:
Guan-Jun Yang, Yan-Jun Liu, Li-Jian Ding, Fan Tao, Ming-Hui Zhu, Zhen-Yuan Shi, Juan-Ming Wen, Meng-Yao Niu, Xiang Li, Zhan-Song Xu, Wan-Jia Qin, Chen-Jie Fei, Jiong Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Breast cancer (BC) is a kind of malignant cancer in women, and it has become the most diagnosed cancer worldwide since 2020. Histone methylation is a common biological epigenetic modification mediating varieties of physiological and pathological proc
Externí odkaz:
https://doaj.org/article/a8e5d42a0630497bb6ff96453077131f
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Breast cancer mainly affects women and causes a severe global threat to health. It is often managed and treated with surgery, chemotherapy, immunotherapy, and radiation therapy. Generally, chemotherapy as a treatment option is often opposed by respon
Externí odkaz:
https://doaj.org/article/6e138dfa4f0d4b6d8b4f54ef4cdc6a57
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Breast cancer has recently been known as the first lethal malignancy in women worldwide. Despite the existing treatments that have improved the patients’ prognosis, some types of breast cancer are serious challenges to treat. Therefore, efforts are
Externí odkaz:
https://doaj.org/article/4942ca62a29f4425a98b552441974bca
Autor:
Yihang Qi, Wenxiang Zhang, Ray Jiang, Olivia Xu, Xiangyi Kong, Lin Zhang, Yi Fang, Jingping Wang, Jing Wang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: The combination of immune checkpoint inhibitors (ICIs) and chemotherapy (CT) is a new strategy to explore cancer treatment in recent years, and it is also practiced in triple-negative breast cancer (TNBC). However, several published rando
Externí odkaz:
https://doaj.org/article/e03066709672448dae46c21756b089d2
Autor:
Panayiota Christodoulou, Panagiotis Boutsikos, Christiana M. Neophytou, Theodora-Christina Kyriakou, Maria-Ioanna Christodoulou, Panagiotis Papageorgis, Anastasis Stephanou, Ioannis Patrikios
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Amygdalin is a naturally occurring glycoside used in traditional Chinese medicine and is known to have anti-cancer properties. Even though the anti-cancer properties of amygdalin are well known, its effect on normal cells has not been thoroughly inve
Externí odkaz:
https://doaj.org/article/6c6697748d8b44b5a3f06f4b2acaa6ab
Autor:
Md Shahin Alam, Adiba Sultana, Hongyang Sun, Jin Wu, Fanfan Guo, Qing Li, Haigang Ren, Zongbing Hao, Yi Zhang, Guanghui Wang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Accurate identification of molecular targets of disease plays an important role in diagnosis, prognosis, and therapies. Breast cancer (BC) is one of the most common malignant cancers in women worldwide. Thus, the objective of this study was to accura
Externí odkaz:
https://doaj.org/article/9b9dfba8d4a44b6a999a9fe68b03f8f6
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Breast cancer is one of the most common malignancies and the leading cause of cancer-related death in women. HER2 overexpression is a factor for poor prognosis in breast cancer, and anti-HER2 therapy improves survival in these patients. A dual-target
Externí odkaz:
https://doaj.org/article/9e5913302a3c4cfd8d82770d1dd162c3
Autor:
Catherine Goetzinger, Caroline Alleaume, Anna Schritz, Bernard Vrijens, Marie Préau, Guy Fagherazzi, Laetitia Huiart
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Up to 50% of breast cancer (BC) survivors discontinue their adjuvant endocrine therapy (AET) before the recommended 5 years, raising the issue of medication non-adherence. eHealth technologies have the potential to support patients to e
Externí odkaz:
https://doaj.org/article/6c3495448e6c4b9fa73f5152c2ba3535